Pharmacotherapy of acute lung injury and acute respiratory distress syndrome

K Raghavendran, GS Pryhuber… - Current medicinal …, 2008 - ingentaconnect.com
Acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) are
characterized by rapid-onset respiratory failure following a variety of direct and indirect …

Pharmacology of acute lung injury

S Tasaka, N Hasegawa, A Ishizaka - Pulmonary pharmacology & …, 2002 - Elsevier
The acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a clinical
syndrome that affects both medical and surgical patients. To date, despite improved …

Emerging drugs for acute lung injury

D Impellizzeri, G Bruschetta, E Esposito… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Acute respiratory distress syndromes (ARDS) are devastating disorders of
overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and …

Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis

N Adhikari, KEA Burns, MO Meade - Treatments in respiratory medicine, 2004 - Springer
Background: Multiple pharmacologic treatments have been studied for patients with acute
respiratory distress syndrome (ARDS) and acute lung injury (ALI). Our objective was to …

Evolution of treatments for patients with acute lung injury

AM Esper, GS Martin - Expert Opinion on Investigational Drugs, 2005 - Taylor & Francis
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are acute life-
threatening forms of hypoxemic respiratory failure. ALI/ARDS patients require intensive care …

Treatment of acute lung injury: historical perspective and potential future therapies

JE Levitt, MA Matthay - Seminars in respiratory and critical care …, 2006 - thieme-connect.com
The acute respiratory distress syndrome (ARDS) was first described by Ashbaugh and
colleagues in 1967. However, despite considerable efforts, early progress in treatment was …

Pharmacological therapy for acute respiratory distress syndrome

R Jain, A DalNogare - Mayo Clinic Proceedings, 2006 - Elsevier
Acute respiratory distress syndrome (ARDS) is an inflammatory process caused by a variety
of direct and indirect injuries to the lungs. Despite improvements in supportive care and …

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

KJ Bosma, JF Lewis - Expert Opinion on Emerging Drugs, 2007 - Taylor & Francis
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a life-threatening form of
respiratory failure that affects a heterogeneous population of critically ill patients. Although …

Pharmacological therapies for acute respiratory distress syndrome

PM Spieth, H Zhang - Current Opinion in Critical Care, 2014 - journals.lww.com
Overall, there is no proven pharmacological therapy in ARDS, but some pharmacological
interventions were associated with beneficial effects in certain subgroups of patients …

Emerging drugs for treating the acute respiratory distress syndrome

TD Shaw, DF McAuley, CM O'Kane - Expert opinion on emerging …, 2019 - Taylor & Francis
Introduction: The acute respiratory distress syndrome (ARDS) is a common and catastrophic
condition, with a high mortality rate and economic burden on society. Despite 50 years of …